Source: NewsFile

Press Release: Epizyme : SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Epizyme, Inc. Merger

Wilmington, Delaware--(Newsfile Corp. - June 28, 2022) - Rigrodsky Law, P.A. is investigating Epizyme, Inc. ("Epizyme") (NASDAQ: EPZM) regarding possible breaches of fiduciary duties and other violations of law related to Epizyme's agreement to be acquired by Ipsen S.A. (OTC Pink: IPSEF). Under the terms of the agreement, Epizyme's shareholders will receive $1.45 in cash and one contingent value right (CVR) of $1.00 for each share of Epizyme common stock they own.To learn more about...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Grant Bogle's photo - President & CEO of Epizyme

President & CEO

Grant Bogle

CEO Approval Rating

85/100

Read more